Abstract:Objective: To investigate the expression of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in hippocampal tissues of rats with vascular dementia, and the monoamine transmitters 5-HT (5-HT), dopamine (DA) and norepinephrine (NE) in cerebral cortex. Methods: 120 clean healthy male SD rats were selected for adaptive culture for 2 weeks. Rats were randomly divided into model group, sham operation group, low-dose butylphthalide group and high-dose butylphthalide group, with 30 rats in each group. Sham operation group, only bilateral common carotid arteries were isolated without ligation. Model group: bilateral common carotid arteries were separated. Low-dose butylphthalide group: ligated bilateral common carotid artery and intraperitoneally injected 3 mg/kg butylphthalide sodium chloride injection; High-dose butylphthalide group: ligated bilateral common carotid artery and intraperitoneally injected 7 mg/kg butylphthalide sodium chloride injection. The model group and the sham operation group were given equal doses of saline intraperitoneally. Morris water maze experiment was used to detect the changes in the time of escape latency, the exploration time of the platform area, the time of effective zone residence and the number of errors. The expression levels of TNF-alpha and IL-1 beta in hippocampal tissues of rats were detected by elisa. The changes of 5-HT, DA and NE in cerebral cortex of rats were determined by immunofluorescence. The changes of hippocampal tissues in each group were observed by HE staining. Results: Compared with the model group, the escape latency time and the number of errors in the high-dose and low-dose butylphthalide groups were significantly reduced, and the exploration time in the plateau area and the stay time in the effective area were significantly increased (P<0.05). Compared with the model group, the levels of TNF-alpha and IL-1 beta in the high-dose, low-dose and sham operation groups were significantly increased, and the levels of TNF-alpha and IL-1 beta in the model group were significantly higher than those at 1 and 6 weeks after the operation (P<0.05). Compared with the model group, the levels of 5-HT, DA and NE in the high-dose, low-dose and sham operation groups were significantly increased (P<0.05). The hippocampal nerve cells in the sham operation group were arranged normally, with dense and large round neurons, obvious nucleoli and distinct cell stratification. The shapes of hippocampal neurons in the high-dose and low-dose butylphthalide groups were regular, with obvious stratification, and there was no significant difference between the two groups. In the model group, the pyramidal cells in the hippocampal of rats were arranged in disorder, and the shape of the cells were irregular, connective tissue such as glial cells proliferate, nodular formation, and the level disappeared. Conclusion: Butylphthalide can inhibit the expression of TNF-alpha and IL-1 beta in hippocampus of rats with vascular dementia, reduce its damage to the nervous system, and increase the levels of 5-HT, DA and NE in vascular dementia rats, and improve the learning and memory ability of rats.

[Butylphthalide Improves Learning and Memory Abilities of Rats with Alzheimer's Disease Possibly by Enhancing Protein Disulfide Isomerase and Inhibiting P53 Expressions].

A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.

Effect of Butylphthalide on Expression of NeuN and IL-1 in Model Rats with Alzheimer disease.

Effect of butylphthalide on ability of learning and memory and ultrastrure in hippocampus CA1 region of alzheimer's disease model rats

l-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-β peptide in rats

Poliumoside inhibits apoptosis, oxidative stress and neuro-inflammation to prevent intracerebroventricular Streptozotocin-induced cognitive dysfunction in Sprague-Dawley Rats: in in-vivo, in-vitro and in-silico study.

EFFECTS OF BUTYLPHTHALIDE ON THE EXPRESSION OF TNF-A AND IL-1B IN HIPPOCAMPUS OF RATS WITH VASCULAR DEMENTIA AND THE EXPRESSION OF 5-HT, DA AND NE IN CEREBRAL CORTEX

L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer’s disease mouse model and cultured hippocampal neurons

Improvement Effects and Mechanism of Dipyridamole on Learning and Memory in Rats with Alzheimer's Disease

Effect of Dl-3-n-butylphthalide on Autophagic Cell Death in Aβ-treated U87 Cells

Butylphthalide alleviates sleep deprivation-induced cognitive deficit by regulating Nrf2/HO-1 pathway

Effect of ginsenoside Rb1 on expression of β-secretase and presenilin-1 in hippocampal formation of Alzheimer's disease-like rats

Dl-3-n-butylphthalide promotes microglial phagocytosis and inhibits microglial inflammation via regulating AGE-RAGE pathway in APP/PS1 mice

Effects of N?butylphthalide on Mitochondria in Hippocampus and Learning and Memory Abilities Inrats with Chronic Alcoholism

L-3-n-Butylphthalide Effectively Improves the Glymphatic Clearance and Reduce Amyloid-β Deposition in Alzheimer’s Transgenic Mice

[The Effect of Butylphthalide on Expression of NGF and BDNF in Ischemia Stroke Tissue of Rat Cerebrum].

Allantoin ameliorates amyloid β-peptide-induced memory impairment by regulating the PI3K/Akt/GSK-3β signaling pathway in rats

Inhibition Of Phosphodiesterase-4 Reverses Memory Deficits Produced By A Beta 25-35 Or A Beta 1-40 Peptide In Rats

Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway

Butylphthalide inhibits ferroptosis and ameliorates cerebral Ischaemia-Reperfusion injury in rats by activating the Nrf2/HO-1 signalling pathway